FMP
NASDAQ
3.44 USD
0.02 (0.581%)
Dr. Gregory A. Demopulos M.D.
Healthcare
Biotechnology
https://www.omeros.com
NASDAQ
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA); that is in Phase III clinical trial for immunoglobulin A nephropathy (IgAN) and atypical hemolytic uremic syndrome (aHUS); and Phase II clinical trial to treat COVID-19. Its clinical programs...
0001285819
US6821431029
682143102
The Omeros Building
206 676 5000
US
196
Oct 8, 2009
0001285819
NASDAQ
Biotechnology
Healthcare
682143102
US6821431029
US
3.44
1.37
603.45k
216.26M
-
0.92-7.8
3.95
-
-
-
-
-1.19
-
https://www.omeros.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.